127 related articles for article (PubMed ID: 6175770)
1. Correlation of serum tumor markers and lymphangiography with degrees of nodal involvement in surgical stage II testis cancer.
Vugrin D; Whitmore WF; Nisselbaum J; Watson RC
J Urol; 1982 Apr; 127(4):683-4. PubMed ID: 6175770
[TBL] [Abstract][Full Text] [Related]
2. Selection of testicular tumor patients for omission of retroperitoneal lymph node dissection.
Herr HW; Whitmore WF; Sogani PC; Watson RC; Fair WR
J Urol; 1986 Mar; 135(3):500-3. PubMed ID: 3944894
[TBL] [Abstract][Full Text] [Related]
3. Computerized tomography and lymphangiography in staging testis tumors.
Ehrlichman RJ; Kaufman SL; Siegelman SS; Trump DL; Walsh PC
J Urol; 1981 Aug; 126(2):179-81. PubMed ID: 6167742
[TBL] [Abstract][Full Text] [Related]
4. The role of tumour markers and lymphography in determining clinical stage of non-seminomatous testis tumours.
Zvara V; Hornák M; Breza J; Krídl J
Czech Med; 1986; 9(1):9-14. PubMed ID: 2423305
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
[TBL] [Abstract][Full Text] [Related]
6. Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.
Beck SD; Foster RS; Bihrle R; Donohue JP
Urology; 2007 Mar; 69(3):557-9. PubMed ID: 17382165
[TBL] [Abstract][Full Text] [Related]
7. Difficulties of a surveillance study omitting retroperitoneal lymphadenectomy in clinical stage I nonseminomatous germ cell tumors of the testis.
Pizzocaro G; Zanoni F; Salvioni R; Milani A; Piva L; Pilotti S
J Urol; 1987 Dec; 138(6):1393-6. PubMed ID: 2824862
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of pedal lymphangiography in staging non-seminomatous testicular carcinoma.
Storm PB; Kern A; Loening SA; Brown RC; Culp DA
J Urol; 1977 Dec; 118(6):1000-3. PubMed ID: 562948
[TBL] [Abstract][Full Text] [Related]
9. Early clinical stages (CS1, CS1Mk+ and CS2A) of non-seminomatous testis cancer. Value of pre- and post-orchiectomy serum tumor marker information in prediction of retroperitoneal lymph node metastases. Swedish-Norwegian Testicular Cancer Project (SWENOTECA).
Klepp O; Flodgren P; Maartman-Moe H; Lindholm CE; Unsgaard B; Teigum H; Fosså SD; Paus E
Ann Oncol; 1990 Jul; 1(4):281-8. PubMed ID: 1702312
[TBL] [Abstract][Full Text] [Related]
10. Relevance of biochemical tumor markers and lymphadenectomy in management of non-seminomatous testis tumors: current perspective.
Skinner DG; Scardino PT
J Urol; 1980 Mar; 123(3):378-82. PubMed ID: 6153725
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of preoperative staging in stages A and B nonseminomatous germ cell testis tumors.
Rowland RG; Weisman D; Williams SD; Einhorn LH; Klatte EC; Donohue JP
J Urol; 1982 Apr; 127(4):718-20. PubMed ID: 6175771
[No Abstract] [Full Text] [Related]
12. Lymphangiography and computerized tomography in testicular carcinoma: how accurate in early stage disease?
Tesoro-Tess JD; Pizzocaro G; Zanoni F; Musumeci R
J Urol; 1985 Jun; 133(6):967-70. PubMed ID: 3999221
[TBL] [Abstract][Full Text] [Related]
13. [Clinical value of testicular lymphangiography in diagnosis of retroperitoneal metastases].
Takasaki N; Matsuse K; Okada S; Ra S; Ueda H; Ogita T
Hinyokika Kiyo; 1984 Nov; 30(11):1599-610. PubMed ID: 6528843
[TBL] [Abstract][Full Text] [Related]
14. Localization of solitary and multiple metastases in stage II nonseminomatous testis tumor as basis for a modified staging lymph node dissection in stage I.
Weissbach L; Boedefeld EA
J Urol; 1987 Jul; 138(1):77-82. PubMed ID: 3599225
[TBL] [Abstract][Full Text] [Related]
15. Tumor volume, CT scan, lymphography, sonography, intravenous pyelography, and tumor markers in testis tumors.
Wilbert DM; Klose KJ; Alken P; Jacobi GH; Hohenfellner R
Urol Int; 1989; 44(1):15-9. PubMed ID: 2473563
[TBL] [Abstract][Full Text] [Related]
16. Experience with serum alpha-fetoprotein and human chorionic gonadotropin in non-seminomatous testicular tumors.
Fowler JE; Taylor G; Blom J; Stutzman RE
J Urol; 1980 Sep; 124(3):365-8. PubMed ID: 6159485
[TBL] [Abstract][Full Text] [Related]
17. [Correlation of tumor proteins and lymphography with findings from lymphadenectomy in nonseminomatous tumors of the testis].
Hornák M; Breza J; Krídl J; Zvara V
Rozhl Chir; 1984 Apr; 63(4):235-40. PubMed ID: 6205455
[No Abstract] [Full Text] [Related]
18. [Staging of testicular cancer by ultrasound and tumor markers with special respect to stage I and IIA].
Behrendt H; Heckemann R; Meyer-Schwickerath M; Hartung R
Urol Int; 1983; 38(5):279-84. PubMed ID: 6195792
[TBL] [Abstract][Full Text] [Related]
19. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
Swanson DA
Semin Urol; 1993 May; 11(2):92-8. PubMed ID: 7689741
[No Abstract] [Full Text] [Related]
20. Germ-cell tumors of the testis: improved results in a prospective study using combined modality therapy and biochemical tumor markers.
Scardino PT; Skinner DG
Surgery; 1979 Jul; 86(1):86-93. PubMed ID: 88077
[No Abstract] [Full Text] [Related]
[Next] [New Search]
